eMC and NICE Clinical Knowledge Summaries are both valuable UK clinical resources, but they are designed for different jobs. An SmPC on eMC describes a particular licensed medicinal product and the conditions attached to its use. NICE CKS is organised around clinical conditions and primary-care management pathways. Neither should be treated as a universal substitute for the other.
The practical comparison
| Question | eMC (SmPCs) | NICE CKS | SPS, specialist and local guidance |
|---|---|---|---|
| What is it? | Regulator-approved information for a licensed product | Condition-led clinical knowledge summaries from NICE | Independent or operational medicines advice for particular settings and questions |
| Best for | Licensed indications, product-specific dosing, contraindications, warnings, interactions, adverse effects, excipients and pharmaceutical particulars | Assessment and management pathways, treatment sequencing, referral, follow-up and safety-netting in primary care | Questions requiring specialist interpretation, practical medicines optimisation or a local formulary decision |
| Organised by | Product, brand, strength and formulation | Condition or presentation | Topic, population, medicine or local pathway |
| Important limitation | Product information is not a complete condition-management pathway and does not compare every treatment option | CKS is not a complete product dossier and does not cover every specialist setting | Scope, access and applicability vary; local policy may differ |
| Access | Searchable on eMC | Searchable on NICE CKS | Use NHS SPS, relevant specialist guidance and your local formulary or medicines-information service |
What an SmPC on eMC tells you
The electronic medicines compendium hosts approved medicines information for products licensed in the UK. The Summary of Product Characteristics is written in a standard numbered format and is intended for healthcare professionals. It is drafted and maintained by the marketing authorisation holder, then checked and approved through the medicines-regulatory process.
The sections clinicians most often need are:
- 4.1 Therapeutic indications: the product’s licensed uses.
- 4.2 Posology and method of administration: product-specific dosing and administration, including adjustments described for relevant populations.
- 4.3 Contraindications: situations in which the product must not be used.
- 4.4 Special warnings and precautions: important risk-management information.
- 4.5 Interactions: known interactions relevant to that product.
- 4.6 Fertility, pregnancy and lactation: approved product information for these circumstances.
- 4.8 Undesirable effects: reported adverse effects and frequency information where available.
- 6.1 Excipients: the formulation ingredients, useful when a specific excipient matters.
Because an SmPC belongs to a specific product, different brands, strengths or formulations of the same active ingredient can have separate documents. Check that the document matches the product you are considering.
What NICE CKS tells you
NICE CKS starts with the patient’s condition rather than a particular medicine. A topic may cover assessment, investigations, first-line and subsequent management, referral thresholds, follow-up and safety-netting. It is especially useful when the question is “What should I do next for this presentation?” rather than “What does the approved product information say about this formulation?”
When a CKS pathway recommends a medicine, use the relevant SmPC on eMC for the product-specific details and check any applicable safety advice, specialist guidance and local formulary requirements.
A safer decision framework
“Is this an approved indication for this product?” Start with section 4.1 of the relevant SmPC on eMC.
“What dose and administration instructions are approved for this product?” Check section 4.2 of the matching SmPC. If the patient or situation falls outside the document’s scope, consult appropriate specialist and local guidance rather than extrapolating.
“What is the recommended management pathway for this condition?” Start with the applicable NICE guideline or CKS topic, then verify any product-specific details in the relevant SmPC.
“Does this formulation contain a particular excipient?” Check the relevant SmPC, especially section 6.1, and make sure the brand and formulation match.
“The case is complex, specialist or outside routine primary-care guidance.” Use the relevant specialist guideline, NHS SPS advice where applicable, your local formulary and a medicines-information or specialist pharmacy service.
Where iatroX sits
Ask iatroX is a search and synthesis layer for clinical questions. iatroX describes its answers as grounded in sources including NICE and CKS guidance, with medicines information from SmPCs via eMC, and provides citations so clinicians can inspect the underlying material.
Use those citations to open the relevant source and confirm that it applies to the patient, product, jurisdiction and date in front of you. iatroX supports professional decision-making; it does not replace clinical judgement, local policy or urgent specialist advice.